BE569211A - - Google Patents
Info
- Publication number
- BE569211A BE569211A BE569211DA BE569211A BE 569211 A BE569211 A BE 569211A BE 569211D A BE569211D A BE 569211DA BE 569211 A BE569211 A BE 569211A
- Authority
- BE
- Belgium
- Prior art keywords
- glutamic acid
- solution
- sodium hydroxide
- temperature
- crystallization
- Prior art date
Links
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 78
- WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 claims description 53
- WHUUTDBJXJRKMK-UHFFFAOYSA-N glutamic acid Chemical compound OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 38
- 229930182847 D-glutamic acid Natural products 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 11
- 230000003287 optical effect Effects 0.000 claims description 8
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 5
- 239000000047 product Substances 0.000 description 24
- 239000004220 glutamic acid Substances 0.000 description 23
- 235000013922 glutamic acid Nutrition 0.000 description 22
- 239000000243 solution Substances 0.000 description 21
- 239000013078 crystal Substances 0.000 description 19
- 238000002425 crystallisation Methods 0.000 description 18
- 230000008025 crystallization Effects 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 5
- 235000013923 monosodium glutamate Nutrition 0.000 description 5
- 239000004223 monosodium glutamate Substances 0.000 description 5
- 238000010899 nucleation Methods 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- OZDAOHVKBFBBMZ-UHFFFAOYSA-N 2-aminopentanedioic acid;hydrate Chemical compound O.OC(=O)C(N)CCC(O)=O OZDAOHVKBFBBMZ-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000012047 saturated solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric Acid Chemical compound [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- UVZZAUIWJCQWEO-DFWYDOINSA-N (2s)-2-aminopentanedioic acid;sodium Chemical compound [Na].OC(=O)[C@@H](N)CCC(O)=O UVZZAUIWJCQWEO-DFWYDOINSA-N 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003385 sodium Chemical class 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE569211A true BE569211A (instruction) |
Family
ID=188261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE569211D BE569211A (instruction) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE569211A (instruction) |
-
0
- BE BE569211D patent/BE569211A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2343275B1 (fr) | Forme cristalline des énantiomères optiques du modafinil. | |
| CA1336348C (fr) | Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese | |
| FR2467211A1 (fr) | Solvats d'ethers alicycliques et d'acide syn-7-(2-(2-amino-4-thiazolyl)-2-methoxyimino) acetamido-3-acetoxymethyl-3-cephem-4-carboxylique, leur preparation et leur utilisation pour la preparation de l'acide libre et de ses sels | |
| FR2562538A1 (fr) | Procede de recristallisation d'explosifs brisants | |
| EP2791098A1 (fr) | Procede de purification de la vanilline par extraction liquide-liquide | |
| BE1008403A4 (fr) | Procede de cristallisation d'iopamidol. | |
| EP0308339B1 (fr) | Procédé de synthèse industrielle de l'acide perhydroindole carboxylique - 2 (2S, 3aS, 7aS). Application à la synthèse de carboxyalkyl dipeptides | |
| FR2832146A1 (fr) | Base libre de tamsulosine racemique et ses procedes de preparation | |
| BE569211A (instruction) | ||
| BE863245A (fr) | Nouveaux composes d'addition d'un derive de dipeptide et d'un derive d'amino-acide, et leur procede de preparation et de decomposition | |
| EP3487835B1 (fr) | Procédé de dédoublement de sels de baclofène | |
| CH625519A5 (instruction) | ||
| WO1998039286A1 (fr) | PROCEDE D'OBTENTION D'ENANTIOMERES D'ACIDES α-AMINES ET SELS DIASTEREOISOMERIQUES INTERMEDIAIRES | |
| CH396027A (fr) | Procédé de dédoublement de la DL-lysine | |
| FR2756557A1 (fr) | Procede de dedoublement de composes 1-amino-alcan-2-ol | |
| CA1111447A (fr) | Composes halogenes, procede de preparation et application a la preparation du metaphenoxy benzaldehyde | |
| BE531142A (instruction) | ||
| WO1997003061A1 (fr) | Procede d'extraction et d'isolement de la 10-desacetylbaccatine iii | |
| BE865027A (fr) | Procede de preparation de la 5-(4-jydroxyphenyl)-hydantoine | |
| FR2505829A1 (fr) | Procede pour l'elimination du groupe n-formyle de peptides n-formyles et d'esters de peptides n-formyles | |
| FR2558838A1 (fr) | Procede de preparation de derives n-acyles d'aspartame | |
| FR2536391A1 (fr) | Nouveaux sels de carnitinenitrile ainsi que leur procede de preparation | |
| CH508590A (fr) | Procédé de préparation des esters d'alcoyle inférieurs de l'a-L-aspartyl-L-phénylalanine | |
| BE542228A (instruction) | ||
| BE885558A (fr) | Procede pour l'extraction de silymarine a partir des plantes silymarine ainsi obtenue et son utilisation en therapeutique |